Physician profile
Naheed I Ahmad
NPI 1922104264
$296,458.50
in general payments reported to CMS, 2019-2025
10 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151K · 2020: $125K · 2021: $2,040 · 2022: $17K · 2023: $274 · 2024: $306 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697 · Entertainment: $86.66 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.35 |
| Entertainment | $86.66 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $275,708.17 | 2019-2025 | Acuvue |
| Allergan, INC. | $14,706.60 | 2019-2022 | |
| Abbvie INC. | $4,641.59 | 2022 | |
| Alcon Vision LLC | $655.57 | 2019-2024 | Precision 1 |
| Bausch & Lomb Americas INC. | $332.00 | 2022-2025 | Eureka, Biotrue One Day, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $198.86 | 2019 | |
| Optos, INC. | $117.09 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $57.20 | 2024 | Onefit Contact Lens |
| Biotissue Holdings INC. | $23.58 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naheed Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.